Benchmark Electronics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Analysts’ updated eps estimates for Monday, April 29th: Acrivon Therapeutics (NASDAQ:ACRV) was downgraded by analysts at LADENBURG THALM/SH SH from a buy rating to a neutral rating. Altimmune (NASDAQ:ALT) was downgraded by analysts at Guggenheim from a buy rating to a neutral rating. Altair Engineering (NASDAQ:ALTR) had its neutral rating reaffirmed by analysts at Rosenblatt […]

Revenue Declines but Margins Improve; Free Cash Flow Remains Strong

/PRNewswire/ -- The medical device manufacturing outsourcing market is expected to grow by USD 46.24 billion from 2022 to 2027. In addition, the momentum of...

Revenue of $720 million, GAAP and non-GAAP earnings per share of $0.57

/PRNewswire/ -- The Adaptive Optics Market is projected to increase at a CAGR of 34.81% during the forecast period. One of the primary drivers behind the...